Farmington, April 28, 2023 (GLOBE NEWSWIRE) -- The Global Marine Biomedicine Market size was valued at USD 6.0 billion in 2022 and is projected to reach USD 11.5 billion by 2030, growing at a CAGR of 8.50% from 2023 to 2030. More research and development will be conducted on marine biotechnology products, and more people and healthcare professionals will learn about the benefits of these products. Biomedicine of the sea is the study of how marine organisms can be used to promote human health. There are still many marine animals that have not been examined, so they could be utilized in biomedical research in numerous ways. It is possible to create drugs from algae or use sea urchins to treat spinal cord injury with marine medicines. In addition, marine biotechnological advancements have already yielded successes in a variety of fields, such as human health, pharmacology, fisheries, environmental recovery or regeneration, food and cosmetics industries, agriculture, and chemical industries, resulting in a growing market. In addition, rising demand from the agricultural and pharmaceutical industries would create growth opportunities for the global marine biotechnology industry in the foreseeable future.
Request Sample Copy of Report “The Global Marine Biomedicine market Size, Share & Trends Estimation Report By Type Outlook (Marine Animal Technology, Marine Plant Technology, Marine Biotechnology), By Application Outlook (Cosmetics, Pharmaceuticals, Fine Chemical, Nutritional Supplements), By End User Industries Outlook (Pharmaceutical, Biotechnological), Region and Forecasts, 2022 - 2030”, published by Contrive Datum Insights.
Segmentation Overview:
Type Outlook:
Marine Animal Technology
In the scientific field known as Marine Animal Technology, sea creatures are used to create medications. This method has been used for centuries to discover new approaches to treat and cure diseases.
Marine Plant Technology
Technology based on marine vegetation has not been utilized as frequently as technology based on marine animals.
Marine Biotechnology
Marine bioengineering is a method to discover and implement novel concepts. It allows individuals to utilize biological substances in novel ways and provides access to them.
Application Outlook
Cosmetics
In cosmetics, marine biomedicine is used to prevent and treat a variety of diseases. Marine biomedicine cosmeceuticals are among the most popular categories of health care products.
Pharmaceuticals
Many diseases, including cancer, cardiovascular disease, and neurological disorders, are treated with pharmaceuticals derived from marine biomedicine.
Fine Chemistry
It is a branch of science that examines the ocean to discover new methods for producing medicines, compounds, enzymes, and other substances and processes.
Nutritional Supplements
Marine nutraceuticals can be categorized as follows: marine lipids (from animals and microalgae), macroalgal polysaccharides, marine probiotics, marine natural colors, chitin and other related products, bioactive marine peptides/enzymes, and vitamins.
End User Outlook
Pharmaceutical
The pharmaceutical industry is responsible for the research, development, production, and distribution of medicines.
Biotechnological
The increasing use of marine products in the food, cosmetics, and agricultural industries drives the marine biotechnology market.
Regional Analysis:
North America is the largest market for medications derived from marine organisms. Some of the most prestigious pharmaceutical and biotechnology companies in the world are headquartered in the region and produce pharmaceuticals and health products from marine sources. This market is also expanding as more consumers purchase cosmetics and other sea-based health care products.
Buy this Premium Research Report@
https://www.contrivedatuminsights.com/buy/231304
Scope of Report:
| Report Attributes | Details |
| Growth Rate | CAGR of 8.5% from 2023 to 2030. |
| Revenue Forecast by 2030 | USD 11.5 billion |
| By Type |
|
| By Application |
|
| By End User |
|
| By Companies |
|
| Regions and Countries Covered |
|
| Base Year | 2022 |
| Historical Year | 2017 to 2022 |
| Forecast Year | 2023 to 2030 |
Market Dynamics:
Drivers and Barriers: The purpose of this study was to help people comprehend how the entire situation has changed by examining the most influential drawing characteristics and influencing factors. In addition, the study identifies obstacles and restrictions that could impede the participants' progress.
Opportunities: Between 2022 and 2030, when the estimate is made, the global market for marine biomedicine is expected to expand rapidly. The market is developing steadily in 2021, and since more and more major players are employing strategies, it is anticipated that the market will continue to expand in the coming years.
Growth factor: Governments are investing more money in their national initiatives on fisheries and coastal ecosystem management to promote the long-term expansion of aquatic resources used for food and employment.
Key Segments Covered:
Top Market Players:
- Aker BioMarine
- CP Kelco US Inc
- Elan Corp, FMC Corp.
- GlycoMar Ltd.
- Lonza Group Ltd.
- MariCal
- Marinova
- New England Biolabs Inc.
- PML Applications Ltd.
- Sea Run Holdings Inc.
- Tequesta Marine Biosciences, and others.
By Type
- Marine Animal Technology
- Marine Plant Technology
- Marine Biotechnology
By Application
- Cosmetics
- Pharmaceuticals
- Fine Chemical
- Nutritional Supplements
By End user
- Pharmaceutical
- Biotechnological
Regions and Countries Covered
- North America: (US, Canada, Mexico, Rest of North America)
- Europe: (Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
- Asia-Pacific:(Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
- The Middle East & Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
- Latin America: (Brazil, Argentina, Rest of Latin America)
- Rest Of the World
Check out more related studies published by Contrive Datum Insights:
- RFID In Healthcare Market- The Global RFID In Healthcare Market is expected to reach USD 1,947.04 million by 2030, at a CAGR of 13.10% over the forecast period 2022-2030.
- Spectroscopy Instruments Market- The Global Spectroscopy Instruments Market size was estimated at USD 14.1 Billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.
- Microarrays Market- The Global Microarrays Market size was estimated at USD 3.72 Billion in 2022 and is expected to surpass USD 8.15 Billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030.
Customization of the Report: The report can be customized as per client needs or requirements.For any queries, you can contact us on anna@contrivedatuminsights.com or +1 215-297-4078. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.
Social: Facebook / LinkedIn / Twitter
Contact Us:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +91 9834816757 | +1 215-297-4078
Email: anna@contrivedatuminsights.com
Website:
https://www.contrivedatuminsights.com
Contrive Datum Insights Press Releases
Latest Contrive Datum Insights Latest Reports
